Alejandro Serna-Gonzalez

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Potential Noninvasive Biomarkers to Assess the Aging Process.

Potential Noninvasive Biomarkers to Assess the Aging Process.

Journal: Expert reviews in molecular medicine

Published: September 15, 2025

Influence of Cellular Aging on Liver Stiffness in Patients With Hepatitis C Virus Achieving Sustained Viral Response.

Influence of Cellular Aging on Liver Stiffness in Patients With Hepatitis C Virus Achieving Sustained Viral Response.

Journal: The Journal of infectious diseases

Published: October 18, 2024

Impact of Nonalcoholic Fatty Liver Disease on the Survival of People Living With HIV.

Impact of Nonalcoholic Fatty Liver Disease on the Survival of People Living With HIV.

Journal: Alimentary pharmacology & therapeutics

Published: November 23, 2023

The absence of seroconversion after exposition to hepatitis C virus is not related to KIR-HLA genotype combinations (GEHEP-012 study).

The absence of seroconversion after exposition to hepatitis C virus is not related to KIR-HLA genotype combinations (GEHEP-012 study).

Journal: Antiviral research

Published: November 18, 2023

Hepatic steatosis after switching to integrase inhibitor-based regimens does not parallel short-term weight gain.

Hepatic steatosis after switching to integrase inhibitor-based regimens does not parallel short-term weight gain.

Journal: AIDS (London, England)

Published: October 25, 2023

Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide.

Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide.

Journal: Open forum infectious diseases

Published: July 11, 2023

Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice.

Response to glecaprevir/pibrentasvir in HIV/HCV-coinfected patients in clinical practice.

Journal: The Journal of antimicrobial chemotherapy

Published: May 17, 2023

A metagenome-wide association study of HIV disease progression in HIV controllers.

A metagenome-wide association study of HIV disease progression in HIV controllers.

Journal: iScience

Published: April 04, 2023

Low rate of vaccination and risk of incident hepatitis A among HIV-infected men who have sex with men in Seville, Southern Spain.

Low rate of vaccination and risk of incident hepatitis A among HIV-infected men who have sex with men in Seville, Southern Spain.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)

Published: February 09, 2023

Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis.

Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis.

Journal: Scientific reports

Published: May 13, 2022

Burden of significant liver damage in people living with HIV after microelimination of the hepatitis C virus.

Burden of significant liver damage in people living with HIV after microelimination of the hepatitis C virus.

Journal: The Journal of infection

Published: March 17, 2022

High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use.

High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use.

Journal: The Journal of infection

Published: February 24, 2022

Showing 1-12 of 36

Last Updated: 09/26/2026